These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12691710)

  • 21. Response to comment on "persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant".
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2006 Jan; 354(1):93-7. PubMed ID: 15913713
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water.
    Benotti MJ; Trenholm RA; Vanderford BJ; Holady JC; Stanford BD; Snyder SA
    Environ Sci Technol; 2009 Feb; 43(3):597-603. PubMed ID: 19244989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
    Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a common priority list of pharmaceuticals relevant for the water cycle.
    de Voogt P; Janex-Habibi ML; Sacher F; Puijker L; Mons M
    Water Sci Technol; 2009; 59(1):39-46. PubMed ID: 19151484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of pharmaceutical residues in drinking water in Poland using a new SPE-GC-MS(SIM) method based on Speedisk extraction disks and DIMETRIS derivatization.
    Caban M; Lis E; Kumirska J; Stepnowski P
    Sci Total Environ; 2015 Dec; 538():402-11. PubMed ID: 26318224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Health Relevance of Pharmaceutically Active Compounds in Drinking Water.
    Khan U; Nicell J
    AAPS J; 2015 May; 17(3):558-85. PubMed ID: 25739816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicological relevance of emerging contaminants for drinking water quality.
    Schriks M; Heringa MB; van der Kooi MM; de Voogt P; van Wezel AP
    Water Res; 2010 Jan; 44(2):461-76. PubMed ID: 19766285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of 70 Environmental Protection Agency priority pharmaceuticals in water by EPA Method 1694.
    Ferrer I; Zweigenbaum JA; Thurman EM
    J Chromatogr A; 2010 Sep; 1217(36):5674-86. PubMed ID: 20678773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada--occurrence and treatment efficiency.
    Kleywegt S; Pileggi V; Yang P; Hao C; Zhao X; Rocks C; Thach S; Cheung P; Whitehead B
    Sci Total Environ; 2011 Mar; 409(8):1481-8. PubMed ID: 21315426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicological relevance of pharmaceuticals in drinking water.
    Bruce GM; Pleus RC; Snyder SA
    Environ Sci Technol; 2010 Jul; 44(14):5619-26. PubMed ID: 20575537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lay people and experts' risk perception of pharmaceuticals in the environment in Southwestern Europe.
    Luís S; Lima ML; Poggio L; Aragonés JI; Courtier A; Roig B; Blanchard C
    Regul Toxicol Pharmacol; 2020 Nov; 117():104783. PubMed ID: 32931895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence patterns of pharmaceuticals in water and wastewater environments.
    Nikolaou A; Meric S; Fatta D
    Anal Bioanal Chem; 2007 Feb; 387(4):1225-34. PubMed ID: 17205270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.
    Heberer T
    Toxicol Lett; 2002 May; 131(1-2):5-17. PubMed ID: 11988354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceuticals in drinking water: is the cure worse than the disease?
    Pomati F
    Environ Sci Technol; 2007 Dec; 41(24):8204. PubMed ID: 18200838
    [No Abstract]   [Full Text] [Related]  

  • 35. Exposure and food web transfer of pharmaceuticals in ospreys (Pandion haliaetus): Predictive model and empirical data.
    Lazarus RS; Rattner BA; Brooks BW; Du B; McGowan PC; Blazer VS; Ottinger MA
    Integr Environ Assess Manag; 2015 Jan; 11(1):118-29. PubMed ID: 25088283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence and risk assessment of pharmaceuticals in surface water and drinking water.
    Sanderson H
    Water Sci Technol; 2011; 63(10):2143-8. PubMed ID: 21977632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants.
    Krishnan K; Carrier R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(3):300-16. PubMed ID: 18781539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
    Boxall AB; Keller VD; Straub JO; Monteiro SC; Fussell R; Williams RJ
    Environ Int; 2014 Dec; 73():176-85. PubMed ID: 25127044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of potential exposure and risk from estrogens in drinking water.
    Caldwell DJ; Mastrocco F; Nowak E; Johnston J; Yekel H; Pfeiffer D; Hoyt M; DuPlessie BM; Anderson PD
    Environ Health Perspect; 2010 Mar; 118(3):338-44. PubMed ID: 20194073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment.
    Zwiener C
    Anal Bioanal Chem; 2007 Feb; 387(4):1159-62. PubMed ID: 17031622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.